ArticleScientific reports2025
Ophtimus-V2-Tx: a compact domain-specific LLM for ophthalmic diagnosis and treatment planning.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Fine-Tuning, Retrieval-Augmented Generation, and Hybrid Adaptation of Language Models for Clinical Decision-Making in Health Care: Systematic Review.Journal of medical Internet research · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Large language models (LLMs) show promise for clinical decision support but often struggle with case-specific reasoning. We present Ophtimus-V2-Tx, an 8-billion-parameter ophthalmology-specialized LLM fine-tuned on more than 10,000 case reports. Evaluation is conducted on a pre-collected dataset. Alongside text metrics (ROUGE-L, BLEU, METEOR) and a semantic similarity score, we use CliBench to map outputs to standardized codes (ICD-10-CM, ATC, ICD-10-PCS) and compute hierarchical F1 (L1-L4 and Full), with code mapping used strictly as an evaluation tool. Ophtimus-V2-Tx is competitive with a state-of-the-art general model and stronger in several settings. It improves text metrics (ROUGE-L 0.40 vs. 0.18; BLEU 0.26 vs. 0.05; METEOR 0.45 vs. 0.29) with comparable semantic similarity. On CliBench, it attains a higher full-code score for secondary diagnosis and ties or leads at selected granular levels for primary diagnosis, while medication and procedure results are close with overlapping confidence intervals. Relative to other ophthalmology-tuned baselines, it shows consistently higher text-generation scores. These findings indicate that a compact, domain-adapted model can approach-or in targeted settings, exceed-large general LLMs on clinically grounded outputs while remaining feasible for on-premise use. We also describe an auditable evaluation pipeline (frozen coding agent, identical prompts, hierarchical metrics) to support reproducibility and future benchmarking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.